Genetic variance explains poor response to common asthma medications

Researchers have identified a biological basis for asthmatic children who do not respond well to corticosteroid treatment — currently the most effective treatment for chronic asthma and acute asthma attack. The study also identifies a genetic pathway that could open the possibility of new therapies for difficult-to-treat patients.